Rob Salvagno, head of corporate development and Cisco Investments, chats about theme investing and his approach to M&A
Seed-focused Pear ups its fund size by 50 percent and adds two partners
Genesys Capital has collected most of the $125 million target set for its third venture fund, adding to the momentum felt of late in Canada’s life-sciences sector. Genesys Ventures III initially closed at $90 million in committed capital, the Toronto-based firm announced this week. That puts the fund more than 70 percent of the way to reaching its final goal, expected early next year, Managing Director Damian Lamb told PE Hub Canada.
The same Union Square Ventures 2008 has performed much better in a UTIMCO portfolio
All four indices drop as the second half of the year kicks off to a slow start
Ignition Partners, which last year raised a $200 million sixth fund to invest in enterprise software, has added Nick Triantos as a venture partner
The NVCA wasn't the only organization to respond to the Republican presidential candidate's plans to reduce the carried-interest tax
Twitter-backer Union Square Ventures ranks on top of WSIB portfolio with an IRR of more than 67 percent, as of December 2015
VCs are seeing that AI technology could improve health and could eventually have a high payoff for investments, too
Diablo Technologies, the Ottawa memory-chip developer, secured $37 million in the close of its Series C financing. The oversubscribed round was backed by three global investors, all of them new to the company. They included Israeli venture firm ICV, which led the Series C’s initial $27 million tranche in January. It was joined in a second $10 million tranche, announced today, by New York's Genesis Capital Advisors and Dubai's GII Tech Ventures. Battery Ventures, BDC Capital, Celtic House Venture Partners and Hasso Plattner Ventures, all longtime backers of Diablo, also invested.